BackIntelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Accounts Payable

Latest accounts payable for IQMDU: $470K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$472999.00

Peer trimmed avg / median

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Accounts Payable History

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) vs. peers: Accounts Payable Comparison

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) FAQ

The latest accounts payable for IQMDU is $470K as of December 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IQMDU's accounts payable moved from $0 to $470K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s operating scale or balance-sheet position.

A accounts payable figure of $470K for IQMDU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IQMDU's accounts payable ($470K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.